Showing results (31-40 of 38) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Acta Haematologica|April 15, 2008
Patient-reported outcomes of deferasirox (Exjade, ICL670) versus deferoxamine in sickle cell disease patients with transfusional hemosiderosis. Substudy of a randomized open-label phase II trialElliott Vichinsky, Zahra Pakbaz, Onyinye Onyekwere, et al.Blood|December 5, 2014
Five hematologic tests and treatments to questionLisa K Hicks, Harriet Bering, Kenneth R Carson, et al.Hematology. American Society of Hematology. Education Program|February 20, 2015
Five hematologic tests and treatments to questionLisa K Hicks, Harriet Bering, Kenneth R Carson, et al.Blood|January 27, 2012
Chelation use and iron burden in North American and British thalassemia patients: a report from the Thalassemia Longitudinal CohortJanet L Kwiatkowski, Hae-Young Kim, Alexis A Thompson, et al.British Journal of Haematology|January 20, 2007
A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell diseaseElliott Vichinsky, Onyinye Onyekwere, John Porter, et al.Pediatric Blood & Cancer|October 22, 2008
One year follow-up of children and adolescents with chronic immune thrombocytopenic purpura (ITP) treated with rituximabBrigitta U Mueller, Carolyn M Bennett, Henry A Feldman, et al.Blood|December 15, 2005
Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpuraCarolyn M Bennett, Zora R Rogers, Daniel D Kinnamon, et al.Pediatrics|December 1, 2021
Preventing Home Medication Administration ErrorsH Shonna Yin, Daniel R Neuspiel, Ian M Paul, et al.Pageof 4